Phase I safety clinical trial of peanut allergy vaccine, Polyvac® Peanut.
Phase of Trial: Phase I
Latest Information Update: 20 Mar 2017
Price : $35 *
At a glance
- Drugs Peanut allergy VLP Vaccine Allergy Therapeutics (Primary)
- Indications Peanut hypersensitivity
- Focus Pharmacodynamics
- 20 Mar 2017 New trial record
- 01 Feb 2017 According toa an Allergy Therapeutics media release, company plans to proceed to Phase I development of this vaccine following completion of this trial.